HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysisSantam Chakraborty, Debdeep Dey, Sanjoy Chatterjee et al.|Radiotherapy and Oncology|2022Cited by 42
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trialSanjoy Chatterjee, Santam Chakraborty, Selvamani Backianathan et al.|Trials|2020Cited by 29
Atypical Presentation of Miliary Tuberculosis With Hepatic Involvement Early After Renal TransplantationCrispin Musumba, Paul Richardson, Debdeep Dey|Clinical Gastroenterology and Hepatology|2012Cited by 5
AB0982 DOMAINS FOR INCLUSION IN A NOVEL TREATMENT RESPONSE MEASURE FOR SYSTEMIC LUPUS ERYTHEMATOSUS (TRM-SLE): RESULTS OF A MODIFIED DELPHI STUDYKim A. Connelly, Maria Dall’Era, Rangi Kandane‐Rathnayake et al.|Annals of the Rheumatic Diseases|2024Cited by 0